Ozawa Clare
- SEC CIK
- 0001746742
No open-market purchases or sales filed in the past year.
Current role at each company
- OYST Oyster Point Pharma, Inc.Directoras of Jan 4, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ozawa Clare as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 2021 (view filing) | Oct 18 | 2 days | Ozawa ClareDirector, 10% Owner | SSale | −550.0K | $14.83 | −$8.16M | −99.1%4.99K after | 4 lots |